Key statistics
As of last trade, Orchestra Biomed Holdings Inc (OBIO:NMQ) traded at 5.79, 37.20% above the 52 week low of 4.22 set on Apr 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.50 |
---|---|
High | 5.79 |
Low | 5.43 |
Bid | 5.69 |
Offer | 5.86 |
Previous close | 5.44 |
Average volume | 59.20k |
---|---|
Shares outstanding | 37.82m |
Free float | 24.81m |
P/E (TTM) | -- |
Market cap | 205.77m USD |
EPS (TTM) | -1.60 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 20:38 GMT.
More ▼
- Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update
- Orchestra BioMed to Participate in Jefferies London Healthcare Conference
- Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update
- Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board of Directors
- Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024
- Orchestra BioMed to Participate in Jefferies Global Healthcare Conference
- Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
- Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents
- Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024
- Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
More ▼